Currently we have 4 patients enrolled. 2 in Phase
Post# of 148175
2 in Phase 1b/2 study,
and 2 under emergency IND protocol.
We have potential to treat over 20 cancers , including , melanoma , brain , throat, lungs , stomach , breast , ovarian , uterine , pancreatic , bladder , thyroid.
and at least 10 autoimmune diseases including GvHD and NASH...